Craft

Advanced
  • Home
  •  / BG Medicine
BG Medicine

BG Medicine

Stock Price

$0

2024-10-29

Market Capitalization

$546 K

2024-10-29

Revenue

$1.6 M

FY, 2015

BG Medicine Summary

Company Summary

Overview
BG Medicine is a life sciences company that develops biomarker-based diagnostic tests for the cardiovascular sectors. Its BGM Galectin-3 Test is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.
Type
Public
Status
Active
Founded
2000
HQ
Plainville, MA, US | view all locations
Website
https://bg-medicine.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • James F. O'Connor, Director

    • Stelios Papadopoulos, Director

      • Paul R. Sohmer, Director, President and CEO

        • Harry W. Wilcox, Chairman

          LocationsView all

          1 location detected

          • Plainville, MA HQ

            United States

            124 Washington St #101

          BG Medicine Financials

          Summary Financials

          Revenue (FY, 2015)
          $1.6M
          Gross profit (FY, 2015)
          $1.1M
          Net income (FY, 2015)
          ($5.3M)
          Cash (FY, 2015)
          $1.5M
          EBIT (FY, 2015)
          ($4.6M)

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX